Venture Leaders Biotech 2025
Date
June 22 - 27, 2025 Boston
Application date
16.01.2025
Location
Boston
Register
The Venture Leaders - the members of the Swiss National Startup Team - have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The Venture Leaders’ startup development program is specifically structured to help them achieve these goals. This intense journey offers 10 selected entrepreneurs an accelerated learning curve and a solid network through their exchanges with their peers in the team, as well as market exposure, feedback from investors and experts, and hands-on business development.
A unique program to Boston June 2025 (22.06 - 27.06.2025)
You belong to the top Biotech startups in Switzerland and want to boost your future? Then apply to be one of the 10 members of the 2025 Swiss National Startup Team Biotech for a rocking week traveling to international hotspots for health science and biotech in Boston.
Venture Leaders Biotech 2024
Don’t miss the opportunity!
The admission process
(Save the dates)
Registration deadline: 16.02.2025
Register your project and apply for one of the 10 seats in the six-day intensive entrepreneurship training program in Boston.
Jury presentation: 19.03.2025 Online
Online presentation of the top 20 applicants to a jury, followed by the announcement of the 10 selected startups.
Kick-off meeting: 05.05.2025 (Swiss Biotech Day, Basel)
Public presentation of the 10 Venture Leaders at the Swiss Biotech Day at the Congress Center in Basel.
Trip to Boston Roadshow: 22.06 - 27.06.2025
An intense deep dive into Boston’s vibrant startup ecosystem.
Those eligible to participate:
- Your startup must be officially incorporated in Switzerland
- You must be ready to grow your business in the US with international investors
- You are focused on building a global biotech startup
Venture Leaders Biotech is organized by Venturelab in partnership with Swissnex Boston and supported by University of Basel, EPF Lausanne, ETH Zurich, Hansjörg Wyss, Kellerhals Carrard, and VISCHER.
GET READY: Venture Leaders Biotech in Boston
Watch impressions from a former Venture Leaders Biotech Roadshow
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
